A team of researchers led by Martin Matzuk at Baylor College of Medicine and James Bradner at Dana-Farber Cancer Institute, have found that a compound called JQ1 acts as an inhibitor to sperm production and mobility.
The tests, carried out on mice, showed there to be no side effects, and that once the JQ1 was no longer given to the mice, fertility returned and their offspring suffered no ill effects.
JQ1 was administered by injection over the course of the study, but researchers are confident that a pill could be created to be just as effective. Discovery of the compound came about by accident, as it was first used in cancer treatment until its effects on fertility were finally recognized.
The findings of the study were published in the journal Cell. Men have hoped for decades for a male contraception pill similar to the kind available to women since the 1960’s; however JQ1 has not been shown to cause hormone fluctuation as most female birth control pills currently do.
If JQ1 or other drugs like it pass through human clinical trials the market could be massive, as recent studies have shown up to 70% of men would be willing to take a birth control pill if it were available.
Jacob Elliot | Elite.